The question of whether to undergo a SLN biopsy for melanoma is a difficult one. It is clear that some experts recommend it while others don't. Where does that leave a patient? In England the National Institute for Clinical Excellence provides decision aids for many conditions. Here is a link to the SLN Decision Aid. Please give it thought and discuss it with your dermatologist or surgeon. The decision is really up to you.
Saturday, April 28, 2018
Monday, April 23, 2018
The Problem With Miracle Cancer Cures
by Robert M. Wachter
April 22, 2018, NY Times
Robert Wachter is Professor and Chairmen of Department of
Medicine at UCSF. His book, “The
Digital Doctor,” (2015) is a great trove of information presented in a
palatable, non-geeky manner.
A new
generation of cancer treatments have become available in recent years. The medical literature now fairly gushes with
terms like “revolutionary” and “cure.” Oncologists
are seeing patients whose cases they once would have pronounced hopeless
experience Lazarus-like responses to these new therapies.
If these new treatments worked most of the time, this would
be an unambiguously happy story. But they don’t. A recent analysis estimated
that about 15 percent of patients with advanced cancer might benefit from
immunotherapy — and it’s all but impossible to determine which patients will be
the lucky ones.
What can we do to alleviate the hype?
·
First,
it turns out that many patients can benefit from palliative approaches even as
they continue aggressive treatment for their cancer.
·
Second,
doctors need more training in how to have these hard conversations with
patients in light of the new cancer treatments. Doctors will need to become
more at ease with the prognostic ambiguity.
·
Finally,
through the federal Cancer Moonshot program, the government is spending
hundreds of millions of dollars to study immunotherapy and other emerging
treatment options for cancer. The sooner we can work out which patients will —
and just as important, won’t — benefit from these approaches, the better.
Let’s
be sure that we don’t rob dying patients of a smaller, more subtle miracle: a
death with dignity and grace, relatively free from pain and discomfort.
Sunday, April 22, 2018
Throw Deep
The
NFL Hall of Fame quarterback Ken Stabler was once being interviewed by Sports
Illustrated when the journalist recited a quote from the author, Jack
London that was near to London’s statue in Oakland:
“I would rather be
ashes than dust!
I would rather that my
spark should burn out in a brilliant blaze than it should be stifled by
dry-rot.
I would rather be a
superb meteor, every atom of me in magnificent glow, than a sleepy and
permanent planet.
The function of man is
to live, not to exist.
I shall not waste my
days trying to prolong them.
I shall use my time.”
When sked
what these words meant to him personally, Stabler replied with the gritty
confidence of a veteran, “Throw deep.”
Subscribe to:
Posts (Atom)
Introduction
In 1885, when John Shaw Billings started the database which would, over time, morph into PubMed he recognized the hopelessness o...
-
by James Le Fanu. BMJ 2018;361:k2794 (June 28, 2018) Profligate prescribing has brought a hidden epidemic of si...
-
by Bill Pennington, NY Times October 6, 2017 I have serious questions about the value and validity of articles like this. T...
-
Osler's bedside library revisited—books for the 21st century: Personal Views Sanjay A Pai and Roop D Gursahani. BMJ. 2005 Dec 17; 33...